BACKGROUNDThe management of diffuse low grade gliomas (LGGs) has seen a paradigmatic shift favoring maximal safe surgical resection (MSR). While this approach is not based on randomized-controlled trials (RCTs), the extent of evidence from observational data has prompted arguments against equipoise in LGG management, thus suggesting an RCT comparing MSR with other surgical options unethical.
展开▼